Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | |
| Sales | 34 |
| Gross Profit | 34 |
| Operating Expenses | 9,562 |
| Operating Income | -9,528 |
| Interest Expense | 42 |
| Other Income | 101 |
| Pre-tax Income | -9,469 |
| Income Tax | 5 |
| Net Income Continuous | -9,474 |
| Net Income | $-9,474 |
| EPS Basic Total Ops | -3,137.18 |
| EPS Basic Continuous Ops | -3,137.18 |
| EPS Diluted Total Ops | -3,137.18 |
| EPS Diluted Continuous Ops | -3,137.18 |
| EBITDA(a) | $-9,152 |